跳至主要内容
临床试验/ChiCTR2000038539
ChiCTR2000038539尚未招募1 期

The effects of mindfulness-based intervention for loneliness on older adults: a randomised controlled trial

General Research Fund2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2021年1月1日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
240
试验地点
2
主要终点
De Jong Gierveld Loneliness Scale

研究概览

简要总结

  1. To evaluate the effects of the MBOA programme in reducing loneliness among older adults in Hong Kong;
  2. To evaluate the effects of MBOA in improving quality of life and decreasing depression, anxiety, and healthcare utilisation among lonely older adults;
  3. To explore whether self- acceptance, monitoring, and rumination are potential mediators of the intervention and outcomes for loneliness, anxiety, depression, quality of life and healthcare use among older adults in Hong Kong.

研究设计

研究类型
Interventional
主要目的
随机平行对照
盲法
None

入排标准

年龄范围
60 至 100(—)
性别
All

入选标准

  • adults aged 60 years and above;
  • normal cognitive functioning such that they can understand the materials delivered in mindfulness training and can complete home practice each week;
  • must have been on stable dosage of psychiatric medications of at least three months, because it can interfere with loneliness measurement; and
  • have a validated Chinese six-item De Jong Gierveld Loneliness Scale score of >= 3 suggesting loneliness

排除标准

  • inability to communicate in and understand Chinese, as the intervention will be conducted in Chinese;
  • possession of a medical or mental health condition rendering him/her incapable of participating in the study; and
  • previous participation in a mindfulness-based training

研究组 & 干预措施

Experimental group

Mindfulness based intervention for Older Adults (MBOA)

Control group

Group Social Contact Control (SCC)

结局指标

主要结局

De Jong Gierveld Loneliness Scale

时间窗: baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).

次要结局

  • Five-level EuroQol-five dimensions (EQ-5D-5L) questionnaire(baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).)
  • Patient Health Questionnaire-9 (PHQ-9)(baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).)
  • State-Trait Anxiety Inventory (STAI)(baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).)
  • Acceptance and Action Questionnaire – II(baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).)
  • Rumination Response Scale(baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).)
  • Mindful Attention Awareness Scale (MAAS)(baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).)
  • Healthcare utilisation record(baseline (T0), post-intervention (T1), and 6 and 12 months post-randomisation (T2 and T3).)

研究者

发起方
General Research Fund

研究点 (2)

Loading locations...

相似试验